Long-term comparative study of Substance-P with methylprednisolone on the development of osteoporosis.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Toxicological Sciences

• Publication date

  2014-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2131/JTS.39.391PMID 24849674
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Steroid-induced diabetes in rheumatologic patients.

  2014cited by this paper
• Steroid‐induced diabetes: a clinical and molecular approach to understanding and treatment

  2014cited by this paper
• Short Course Infliximab and Extracorporeal Photopheresis As Therapy For Steroid-Refractory Acute Gvhd In Matched Related and Unrelated Allogeneic Hematopoietic Cell Transplant (HCT)

  2013cited by this paper
• Early-onset Pericardial Effusion after Autologous Hematopoietic Stem Cell Transplantation in a Child with Neuroblastoma

  2013cited by this paper
• Substance P reduces apoptotic cell death possibly by modulating the immune response at the early stage after spinal cord injury

  2013cited by this paper
• Substance P induces M2-type macrophages after spinal cord injury

  2012cited by this paper
• Substance P stimulates the recovery of bone marrow after the irradiation

  2011cited by this paper
• Substance P signaling mediates BMP‐dependent heterotopic ossification

  2011cited by this paper
• A new paradigm for stem cell therapy: Substance-P as a stem cell-stimulating agent

  2011cited by this paper
• Sensory nerve induced inflammation contributes to heterotopic ossification

  2011cited by this paper
• The International Journal of Biochemistry & Cell Biology. Preface.

  2011cited by this paper
• Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro.

  2009cited by this paper
• A new role of substance P as an injury-inducible messenger for mobilization of CD29+ stromal-like cells

  2009cited by this paper
• A composition for preventing or treating anti-inflammatory disease or infectious disease comprising extracts isolated from ligustrum obtusifolium s. et z

  2009cited by this paper
• Substance P accelerates intestinal tissue regeneration after γ‐irradiation–induced damage

  2009cited by this paper
• Heparanase regulates retention and proliferation of primitive Sca-1+/c-Kit+/Lin- cells via modulation of the bone marrow microenvironment.

  2008cited by this paper
• Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling

  2007cited by this paper
• Osteoporotic fractures: mortality and quality of life.

  2007cited by this paper
• Substance P: structure, function, and therapeutics.

  2004cited by this paper
• The role of substance P in inflammatory disease

  2004cited by this paper
• Substance P-induced activation of p42/44 mitogen-activated protein kinase associated with cell proliferation in human tracheal smooth muscle cells.

  2002cited by this paper
• Substance p.

  2001cited by this paper
• The dynamics of bone marrow stromal cells in the proliferation of multipotent hematopoietic progenitors by substance P: an understanding of the effects of a neurotransmitter on the differentiating hematopoietic stem cell.

  2001cited by this paper
• THE SPINAL CORD

  2001cited by this paper
• Biochemical Markers as Predictors of Rates of Bone Loss After Menopause

  2000cited by this paper
• Neurotransmitters and receptors in the dorsal horn of the spinal cord

  2000cited by this paper
• Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children.

  2000cited by this paper
• A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnover.

  1999cited by this paper
• Use of bone alkaline phosphatase to monitor alendronate therapy in individual postmenopausal osteoporotic women.

  1999cited by this paper
• Rapid Bone Loss Is Associated with Increased Levels of Biochemical Markers

  1998cited by this paper
• Hematopoietic regulation mediated by interactions among the neurokinins and cytokines.

  1997cited by this paper
• Human monocytes and macrophages express substance P and neurokinin-1 receptor.

  1997cited by this paper
• The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activation.

  1997cited by this paper
• Mortality following fractures in older women. The study of osteoporotic fractures.

  1997cited by this paper
• Mortality Following Fractures in Older Women: The Study of Osteoporotic Fractures

  1996cited by this paper
• Multiple Forms of Human Serum Alkaline Phosphatase: Detection and Quantitation

  1993cited by this paper
• Modulation of the mRNAs encoding substance P and its receptor in rat macrophages by LPS.

  1992cited by this paper
• Ultrastructural morphometric study of efferent nerve terminals on murine bone marrow stromal cells, and the recognition of a novel anatomical unit: the "neuro-reticular complex".

  1990cited by this paper

• Emerging roles of nerve‐bone axis in modulating skeletal system

  2024cites this paper
• Transcriptomic analysis of World Trade Center particulate Matter-induced pulmonary inflammation and drug treatments.

  2023cites this paper
• Targeted delivery of dexamethasone in acute pneumonia.

  2021cites this paper
• Substance P enhances the therapeutic effect of MSCs by modulating their angiogenic potential

  2020cites this paper
• Metabolomics Based Profiling of Dexamethasone Side Effects in Rats

  2018cites this paper
• Effects of water extract from epimedium on neuropeptide signaling in an ovariectomized osteoporosis rat model.

  2018cites this paper
• Short Anabolic Peptides for Bone Growth

  2016cites this paper
• Effect of glucocorticoid withdrawal on glucocorticoid inducing bone impairment.

  2016cites this paper
• Substance P incorporation in calcium phosphate cement for dental alveolar bone defect restoration.

  2016cites this paper
• Evaluation of substance-P toxicity with single dose and repeated dose in rats

  2015cites this paper
• Effect of substance P on recovery from laser‐induced retinal degeneration

  2015cites this paper
• Variance of spinal osteoporosis induced by dexamethasone and methylprednisolone and its associated mechanism.

  2015cites this paper
• Substance P enhances mesenchymal stem cells-mediated immune modulation.

  2015cites this paper